MGRX
Mangoceuticals, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.41
+5.30%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
Market Cap
$8.86M
MomentumView details →
1D Return
+5.30%
YTD Return
−43.92%
RSI (14)
47.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
Market Cap
$8.86M
RSI (14)
47.9
MomentumView details →
1D Return
+5.30%
YTD Return
−43.92%
SummaryUpdated Jun 1, 2026
Mangoceuticals, Inc. (NASDAQ:MGRX) is a Dallas-based telemedicine company that was incorporated in 2021 and went public in March 2023. The company operates as a subsidiary of Cohen Enterprises, Inc. and focuses on the men's wellness market through direct-to-consumer telemedicine services. Since its IPO, the company has been working to establish itself in the competitive digital health space, though it continues to face significant operational challenges as it scales its business model.
Similar companies
Latest newsMore news →
Nasdaq granted Mangoceuticals, Inc. a 180-day extension to regain compliance with the minimum bid price requirement, extending the deadline to February 1, 2027.31d agoMangocEuticals, Inc. completed a private placement of 850,000 shares of restricted common stock to an accredited investor, raising $272,000 at $0.32 per share, exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.65d ago